Dr. Eun Jung Lee stated, “We are about to complete the optimization of the PROX1-neutralizing antibody (CLZ001) and move to preclinical studies before ... and the Korea Drug Development Foundation ...

Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

The publication sheds light on the selective targeting of ROS1 drug-resistant mutations by zidesamtinib, particularly the common G2032R mutation. Preclinical studies have shown zidesamtinib to ...

announced robust preclinical data supporting the mechanism of action for its leading drug candidate, micvotabart pelidotin (MICVO), and its continued clinical development. According to ...

Introducing our In Focus on organ-on-a-chip (OoC) technology in drug development, this video explores what OoCs are, how they work and how they can be used in drug development to reduce the number of ...